A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom

scientific article published on 13 December 2019

A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41433-019-0664-Z
P932PMC publication ID7608203
P698PubMed publication ID31836832

P50authorParizad AvariQ89691580
P2093author name stringPetros Perros
Colin Dayan
Ben Williams
Vickie Lee
British Oculoplastic Surgery Society (BOPSS) and TEAMeD
P2860cites workConsensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.Q34010116
Assessing quality of life in Australian patients with Graves' ophthalmopathyQ35591594
Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinoloneQ35592595
Orbital decompression for Graves' orbitopathy in EnglandQ35820372
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyQ36811289
Quality of life in thyroid eye disease: impact of quality of careQ37849042
Treatment options for Graves' orbitopathyQ37992118
Evaluating Graves' orbitopathyQ38013209
What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic review.Q38223449
Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists.Q38285063
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.Q38692635
Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease auditQ38906232
Public health relevance of Graves' orbitopathyQ43428269
The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide surveyQ43579038
Incidence of hyperthyroidism in SwedenQ46963719
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experienceQ47945181
The Psychosocial and Clinical Outcomes of Orbital Decompression Surgery for Thyroid Eye Disease and Predictors of Change in Quality of LifeQ47952058
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.Q49360067
Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial.Q49360082
Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathwaysQ62000454
Management of patients in a combined thyroid eye clinic in secondary careQ62000474
A questionnaire survey on the management of Graves' orbitopathy in EuropeQ79988590
Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patientsQ82793494
The Amsterdam Declaration on Graves' orbitopathyQ83056514
Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxisQ84148014
Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection MethodQ88407827
P921main subjectUnited KingdomQ145
eye diseaseQ3041498
P577publication date2019-12-13
P1433published inEyeQ10278937
P1476titleA survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom

Search more.